Ausgabe 5/2022
Inhalt (6 Artikel)
- Germline Predisposition to Myeloid Neoplasms (M. Patnaik, Section Editor)
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms
Mia J. Sullivan, Elizabeth L. Palmer, Juliana Perez Botero
- Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar, Timothy Chlon
- Open Access
- Chronic Myeloid Leukemias (V Oehler, Section Editor)
Management of Chronic Myeloid Leukemia in Children and Young Adults
Maegan Ford, Michael Mauro, Catherine Aftandilian, Kathleen M. Sakamoto, Nobuko Hijiya
- Open Access
- Myeloproliferative Neoplasms (P Bose, Section Editor)
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
Barbara Mora, Francesco Passamonti
- Myeloproliferative Neoplasms (P Bose, Section Editor)
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors
Julian A. Waksal, John Mascarenhas
- Myeloproliferative Neoplasms (P Bose, Section Editor)
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Ivan Krecak, Marko Lucijanic, Srdan Verstovsek